
    
      Clinical trial phase III, randomized, double-blind, prospective, comparative non-inferiority
      to evaluate the efficacy and tolerability of using APETIVITON BC compared to Petivit BC
      stimulation of appetite in children, adults and elderly. A total of 150 patients, distributed
      as follows:

      25 patients treated children Apetiviton BC,25 patients treated children Petivit BC, (2-6
      years).

      25 adult patients treated with Apetiviton BC,25 adult patients treated with Petivit BC,
      (18-50 years.

      25 elderly patients treated with Apetiviton BC,25 elderly patients treated with Petivit BC.
      (60-80 years.
    
  